# Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.

> **NCT07429071** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Aarhus** · enrollment: 70 (estimated)

## Conditions studied

- Womens Health
- Cervical Dysplasia
- Cervical Intraepithelial Neoplasia (CIN)
- Non-invasive Treatment
- Human Papilloma Virus (HPV)

## Interventions

- **COMBINATION_PRODUCT:** Papilocare Vaginal Gel

## Key facts

- **NCT ID:** NCT07429071
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2026-08
- **Final completion:** 2026-09
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07429071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07429071, "Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07429071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*